Events › B2B Event
B2B Event
4th edition
A targeted, high-level summit focused on optimizing donor selection, cell sourcing strategies, and ethical, regulatory compliance for allogeneic cell therapies. It brings together industry, academia, and regulatory experts to discuss challenges in cell procurement and sourcing quality.
Filter this event to your ICP.
A curated group of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Hanson WadePE-backed · London, United Kingdom · Founded 2008
Hanson Wade is a global conference organizer and market intelligence provider focused primarily on the life sciences and biopharma sectors.
Why people attend
To secure high-quality cell sources, ensure regulatory compliance in supply chain, and connect with partners in cell therapy development.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
17 speakers at Donor Selection & Cell Source Summit
"Peanut Butter & Jelly – Sandwiching Stem Cells & Engineered Immune Effector Cells from Same Donor"
Stacey Cranert Seminars
"Fireside Chat: What Does Variability Mean for Allogeneic Cell Therapy Production?"
"Maximizing Process Yield Through Understanding Donor Variability"
"Fireside Chat: What Does Variability Mean for Allogeneic Cell Therapy Production?"
Associate Director, Head of Formulation and Cryobiology · Bristol Myers Squibb
Also speaking at 2nd Edition of Cell & Gene Therapy World Conference (CGTWC )
Tracy Ryan Seminars
"What Makes a Super Donor? Rethinking Selection Through Immune Function & Lifestyle"
Founder & Chief Scientific Officer · Indaptus Therapeutics, Inc.
Also speaking at Government Innovation Week Alberta
"Fireside Chat: What Does Variability Mean for Allogeneic Cell Therapy Production?"
+ 1 more speakers at this event.
More events in United States
Frequently asked questions